ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
企業コードICUI
会社名ICU Medical Inc
上場日Mar 31, 1992
最高経営責任者「CEO」Mr. Vivek Jain
従業員数15000
証券種類Ordinary Share
決算期末Mar 31
本社所在地951 Calle Amanecer
都市SAN CLEMENTE
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号92673-6212
電話番号19493662183
ウェブサイトhttps://www.icumed.com/
企業コードICUI
上場日Mar 31, 1992
最高経営責任者「CEO」Mr. Vivek Jain
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし